tiprankstipranks
Trending News
More News >
Aucfan Co., Ltd. (JP:3674)
:3674
Japanese Market

Aucfan Co., Ltd. (3674) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Aucfan Co., Ltd.

(3674)

Rating:58Neutral
Price Target:
Aucfan Co., Ltd. faces challenges in financial performance, with declining revenues and concerning cash flow issues. While the balance sheet is stable, profitability remains limited. Technical analysis shows mixed signals with bearish momentum, and valuation indicates the stock is fairly priced. The absence of a dividend yield further impacts the stock's appeal.

Aucfan Co., Ltd. (3674) vs. iShares MSCI Japan ETF (EWJ)

Aucfan Co., Ltd. Business Overview & Revenue Model

Company DescriptionAucfan Co., Ltd. (3674) is a Japanese company that operates primarily in the e-commerce and information services sectors. The company is well-known for its online platform that aggregates and provides auction and e-commerce data, helping users make informed decisions based on market trends and insights. Aucfan's services cater to both individual consumers and businesses, offering tools for price comparison, market analysis, and product evaluation.
How the Company Makes MoneyAucfan Co., Ltd. generates revenue through a variety of streams centered around its data aggregation and analysis capabilities. The company offers subscription-based services where users pay for access to detailed auction and e-commerce market data. Additionally, Aucfan earns money by providing analytical tools and solutions to businesses that require insights into consumer behavior and market trends. The company may also generate revenue through partnerships with other e-commerce platforms, leveraging its data to enhance their service offerings. Advertising and affiliate marketing could be additional revenue streams, as the company can monetize the traffic to its online platform by promoting products or services relevant to its user base.

Aucfan Co., Ltd. Financial Statement Overview

Summary
Aucfan Co., Ltd. presents a mixed financial picture. The income statement reveals declining revenues and limited profitability, with a net profit margin of 3.99%. The balance sheet shows stability with a healthy debt-to-equity ratio of 0.38, but the ROE is modest at 4.40%. Cash flow is a significant concern, with zero operating and free cash flow for TTM 2024, indicating potential liquidity issues.
Income Statement
65
Positive
Aucfan Co., Ltd. has seen declining revenue over the years, from 8.38 billion in 2021 to 4.85 billion in TTM 2024, indicating a significant revenue shrinkage. The gross profit margin is strong at 55.96% for TTM 2024, suggesting efficient cost management. However, the net profit margin for TTM 2024 is 3.99%, which is relatively low, indicating limited profitability. EBIT and EBITDA margins are moderate, at 7.21% and 11.63% respectively, reflecting constrained operational profitability.
Balance Sheet
70
Positive
The company has a healthy debt-to-equity ratio of 0.38 in TTM 2024, reflecting manageable leverage. The equity ratio is robust at 56.75%, indicating solid financial stability. However, the return on equity (ROE) is modest at 4.40%, suggesting that the company is not generating high returns on its equity. Overall, the balance sheet is stable but shows room for improvement in profitability.
Cash Flow
40
Negative
Cash flow metrics are concerning with zero operating and free cash flow for the TTM 2024 period, indicating potential liquidity issues. Historical data shows fluctuation in free cash flow, with a negative trend noted recently. The operating cash flow to net income ratio and free cash flow to net income ratio can't be evaluated for TTM 2024, but prior ratios indicate a need for better cash management.
Breakdown
TTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income StatementTotal Revenue
4.85B4.84B5.15B6.26B8.38B7.87B
Gross Profit
2.72B2.68B2.57B3.24B3.53B3.13B
EBIT
350.19M356.36M304.23M322.24M578.67M820.88M
EBITDA
564.44M552.83M312.64M672.02M713.57M1.08B
Net Income Common Stockholders
193.44M187.45M17.08M56.50M177.55M428.69M
Balance SheetCash, Cash Equivalents and Short-Term Investments
4.70B5.59B4.86B5.23B6.09B10.00B
Total Assets
7.75B7.69B7.10B7.35B8.49B13.38B
Total Debt
1.68B1.66B1.27B1.48B1.70B2.17B
Net Debt
-3.03B-2.84B-2.01B-2.35B-1.40B-536.14M
Total Liabilities
3.35B3.28B2.47B2.79B3.03B5.27B
Stockholders Equity
4.39B4.41B4.63B4.56B5.46B8.11B
Cash FlowFree Cash Flow
0.00790.02M-283.82M767.78M852.34M515.65M
Operating Cash Flow
0.001.00B109.91M1.08B1.13B824.01M
Investing Cash Flow
0.00-206.78M-376.05M-263.40M-276.76M-287.41M
Financing Cash Flow
0.00431.87M-332.18M-82.97M-456.39M813.36M

Aucfan Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price350.00
Price Trends
50DMA
359.86
Negative
100DMA
371.29
Negative
200DMA
369.15
Negative
Market Momentum
MACD
-1.75
Positive
RSI
45.31
Neutral
STOCH
36.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3674, the sentiment is Negative. The current price of 350 is below the 20-day moving average (MA) of 356.50, below the 50-day MA of 359.86, and below the 200-day MA of 369.15, indicating a bearish trend. The MACD of -1.75 indicates Positive momentum. The RSI at 45.31 is Neutral, neither overbought nor oversold. The STOCH value of 36.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3674.

Aucfan Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥4.46B21.80
13.96%200.83%
72
Outperform
¥3.87B19.23
1.27%-2.62%
65
Neutral
¥2.90B
0.91%19.56%-906.44%
61
Neutral
$14.30B5.71-4.20%3.66%2.74%-35.53%
58
Neutral
¥3.74B47.12
-2.91%-48.56%
57
Neutral
¥3.34B3,633.15
14.51%84.03%
45
Neutral
¥4.74B
0.85%-2.38%-40.23%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3674
Aucfan Co., Ltd.
353.00
-68.00
-16.15%
JP:2454
All About, Inc.
345.00
-41.78
-10.80%
JP:3645
Medical Net,Inc.
317.00
-47.64
-13.06%
JP:3691
DIGITAL PLUS, Inc.
752.00
225.00
42.69%
JP:3770
Zappallas, Inc.
391.00
-34.74
-8.16%
JP:3930
Hatena Co., Ltd.
1,467.00
667.00
83.38%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.